Newhall Pharmacy, a seven-year-old pharmacy in California, had its license revoked by state authorities after an investigation found it was dispensing opioids to patients without valid prescriptions, according to The Santa Clarita Valley Signal.

In a major win for  Boston-based Dana-Farber Cancer Institute, a federal court ruled that one of its researchers should be listed as an inventor on six patents that are believed to be worth billions of dollars.

In a victory for Merck, the U.S. Supreme Court threw out a lower court decision May 20 that had revived a class-action lawsuit accusing the drugmaker of failing to warn patients of risks associated with its osteoporosis drug Fosamax, according…

Here are 10 hospitals and health systems that posted job listings seeking pharmacy leaders in the last week.

Hyannis, Mass.-based Cape Cod Healthcare will close two retail pharmacies and reduce hours at a third by June 1, according to the Cape Cod Times.

CMS issued a final rule May 16 that makes several changes to Medicare Advantage and Part D. The final rule is a scaled-back version of the proposed rule.

Nestlé, a Swiss consumer goods giant, has entered exclusive talks to sell its skin health business to a consortium led by private equity firm EQT Partners for $10.1 billion, according to The Wall Street Journal.

Five more U.S. states filed lawsuits accusing Purdue Pharma of contributing to the nationwide opioid epidemic by illegally marketing and selling OxyContin, according to Reuters.

The Metropolitan Museum of Art will stop accepting donations from the family that owns OxyContin maker Purdue Pharma, according to The New York Times.

CVS Health is launching a new program that will require third-party testing on all vitamins and supplements sold at its stores to ensure accuracy of the dietary ingredients and guard against contamination.